KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Prepaid Assets: 2010-2024

Historic Prepaid Assets for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to $26.9 million.

  • Emergent BioSolutions' Prepaid Assets fell 58.03% to $25.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.6 million, marking a year-over-year decrease of 58.03%. This contributed to the annual value of $26.9 million for FY2024, which is 43.84% down from last year.
  • Latest data reveals that Emergent BioSolutions reported Prepaid Assets of $26.9 million as of FY2024, which was down 43.84% from $47.9 million recorded in FY2023.
  • Emergent BioSolutions' Prepaid Assets' 5-year high stood at $70.2 million during FY2021, with a 5-year trough of $26.9 million in FY2024.
  • Moreover, its 3-year median value for Prepaid Assets was $47.9 million (2023), whereas its average is $44.2 million.
  • In the last 5 years, Emergent BioSolutions' Prepaid Assets skyrocketed by 92.33% in 2021 and then slumped by 43.84% in 2024.
  • Over the past 5 years, Emergent BioSolutions' Prepaid Assets (Yearly) stood at $36.5 million in 2020, then soared by 92.33% to $70.2 million in 2021, then declined by 17.52% to $57.9 million in 2022, then decreased by 17.27% to $47.9 million in 2023, then tumbled by 43.84% to $26.9 million in 2024.